Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doses”

41,754 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41,754 results

Early research (Phase 1)Study completedNCT02919800
What this trial is testing

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Who this might be right for
Hemophilia A or B With Inhibitors
OPKO Health, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT00761007
What this trial is testing

Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)

Who this might be right for
Irritable Bowel Syndrome
Menarini Group 554
Early research (Phase 1)Looking for participantsNCT06723236
What this trial is testing

MGC028 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNSCLC AdenocarcinomaCholangiocarcinoma+2 more
MacroGenics 124
Testing effectiveness (Phase 2)Study completedNCT00331136
What this trial is testing

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Medicines for Malaria Venture 60
Early research (Phase 1)Study completedNCT03273192
What this trial is testing

CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects

Who this might be right for
BioequivalencePhase 1
Cinnagen 74
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)Study completedNCT01592500
What this trial is testing

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Who this might be right for
Pediatric Growth Hormone Deficiency
OPKO Health, Inc. 56
Not applicableUnknownNCT03535207
What this trial is testing

High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Early research (Phase 1)Study completedNCT01957007
What this trial is testing

Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 34
Early research (Phase 1)Study completedNCT01241292
What this trial is testing

Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 7
Early research (Phase 1)Study completedNCT01772836
What this trial is testing

Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

Who this might be right for
Healthy VolunteersBacterial Infections
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03326336
What this trial is testing

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

Who this might be right for
Non-syndromic Retinitis Pigmentosa
GenSight Biologics 10
Early research (Phase 1)Study completedNCT05984992
What this trial is testing

The First-in-human Study of SRN-001 in Healthy Participants

Who this might be right for
Idiopathic Pulmonary Fibrosis
siRNAgen Therapeutics Inc. 25
Large-scale testing (Phase 3)Study completedNCT01229800
What this trial is testing

Efficacy, Safety and Tolerability of Split-dose of PEG Compared With NaP Solution for Colonoscopy Preparation: A Randomized, Controlled Trial

Who this might be right for
Bowel Preparation, Efficacy, Tolerability, Safety
Inje University 207
Early research (Phase 1)Study completedNCT04163107
What this trial is testing

Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Norwegian University of Science and Technology 19
Early research (Phase 1)Study completedNCT02365571
What this trial is testing

LY3154207 in Healthy Participants

Who this might be right for
Healthy Participants
Eli Lilly and Company 64
Early research (Phase 1)Study completedNCT01959971
What this trial is testing

Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol

Who this might be right for
Hypercholesterolemia
Sanofi 20
Testing effectiveness (Phase 2)UnknownNCT06334367
What this trial is testing

Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT

Who this might be right for
GVHD
Wang Xin 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05453500
What this trial is testing

Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
University of Washington 32
Next Page